
FDA Approves Promega’s OncoMate® MSI Dx System as a Companion Diagnostic for KEYTRUDA® in MSI-High Solid Tumors
Promega Receives FDA Approval for OncoMate® MSI Dx System as Companion Diagnostic for Merck’s KEYTRUDA® Promega has received approval from the U.S. Food and Drug Administration (FDA) for its OncoMate®…














